DiscoveryBioMed

About:

DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company,

Top Investors: National Institutes of Health, NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)

Description:

DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company, located in Birmingham, AL, formed with the ultimate goal of integrating human cell physiology with the drug discovery critical path. DBM’s founder, Erik Schwiebert, Ph.D., a physiologist by trade, launched the company in October 2007 and closed on seed capital investment with Greer Capital Advisors in November of 2007 (Birmingham Technology Fund). Since then DBM has continued to grow and gain recognition both locally and nationally.

Total Funding Amount:

$1.61M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Birmingham, Alabama, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)discoverybiomed.com

Founders:

Erik Schwiebert

Number of Employees:

1-10

Last Funding Date:

2020-04-29

IPO Status:

Private

Industries: